What's Happening?
QT Imaging Holdings has achieved a significant milestone with the approval of a new AMA Category III CPT code for its 3D breast ultrasound tomography technology. This code, effective January 1, 2027, will facilitate billing and open new commercial opportunities
with hospital accounts. The technology offers a radiation-free, compression-free imaging option, enhancing breast health management. The approval reflects years of development and collaboration with the medical community, aiming to expand access to safer breast imaging options and support clinical decision-making.
Why It's Important?
The approval of the CPT code is a crucial step for QT Imaging in gaining broader acceptance and reimbursement for its innovative imaging technology. This development could lead to increased adoption of the technology in hospitals, improving breast cancer detection and diagnosis. The radiation-free aspect of the technology addresses safety concerns associated with traditional imaging methods, potentially attracting more patients and healthcare providers. The milestone also positions QT Imaging as a leader in the medical imaging field, with the potential to influence future advancements in breast health management.
